Company intelligence / Profile preview

Organ Recovery Systems

Des Plaines, Illinois, United Statesorgan-recovery.com ↗

Ownership: Private
Employees: ~51
Development stage: Commercial

Overview

Organ Recovery Systems has commercialized the LifePort Kidney Transporter and LifePort Liver Transporter, which are widely used in transplant centers worldwide. The company’s technologies have preserved over 250,000 kidneys as of June 2025. Their products have won multiple industry awards for innovation and customer service. Clinical studies such as the PILOT™ Continued Access study support their efficacy in improving transplant outcomes.

Therapeutic areas: Immunology
Modalities: Device (Organ perfusion and preservation devices)Solution (Organ preservation solutions)
Industry: Therapeutic Medical Devices

Partnerships

Collaborates with over 100 leading transplant programs globally; specific pharma/biotech partnerships not detailed

Beyond the preview

Go deeper on Organ Recovery Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Organ Recovery Systems.